Literature DB >> 21993829

Malignant gliomas: early diagnosis and clinical aspects.

A Silvani1, P Gaviani, E Lamperti, A Botturi, D Ferrari, G Simonetti, A Salmaggi.   

Abstract

Brain tumor symptoms vary greatly from person to person because of two factors: location and size of tumors. The size of a tumor, however, does not necessarily affect the severity of symptoms. Manifestations depend on the cause of the symptoms: an increase in ICP, direct compression of gray or white matter, shifting of intracranial contents, or secondary cerebral ischemia. Symptoms may be non-specific and include headache, altered mental status, ataxia, nausea, vomiting, weakness, and gait disturbance. Left-sided weakness may be seen in a patient with a tumor pressing on the contra-lateral motor strip or speech difficulties may occur if a tumor is in the dominant hemisphere. Up to a third of people report having seizures prior to being diagnosed with a brain tumor. Rarely, brain tumor can present with psychiatric symptoms but without other neurological signs or symptoms. Evaluation for brain tumor is indicated in any patient with chronic, persistent headache associated with protracted nausea, vomiting, seizures, changes in headache pattern, neurologic symptoms, and change in personality.

Entities:  

Mesh:

Year:  2011        PMID: 21993829     DOI: 10.1007/s10072-011-0788-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  5 in total

1.  Brain tumor location and psychiatric symptoms: is there any association? A meta-analysis of published case studies.

Authors:  Subramoniam Madhusoodanan; Mark G A Opler; Despina Moise; Jessica Gordon; Deepa M Danan; Abhishek Sinha; Ramesh P Babu
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

Review 2.  Epilepsy in brain tumor patients.

Authors:  Andrea O Rossetti; Roger Stupp
Journal:  Curr Opin Neurol       Date:  2010-12       Impact factor: 5.710

Review 3.  Clinical manifestation of central nervous system tumor.

Authors:  Soha A Alomar
Journal:  Semin Diagn Pathol       Date:  2010-05       Impact factor: 3.464

Review 4.  Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.

Authors:  Melanie S M van Breemen; Erik B Wilms; Charles J Vecht
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

Review 5.  Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors.

Authors:  Christina A Meyers; Paul D Brown
Journal:  J Clin Oncol       Date:  2006-03-10       Impact factor: 44.544

  5 in total
  5 in total

1.  Active endocytosis and microtubule remodeling restore compressed pyramidal neuron morphology in rat cerebral cortex.

Authors:  Shih-Hao Huang; Yueh-Jan Wang; Guo-Fang Tseng; Han-Chen Ho
Journal:  Cell Mol Neurobiol       Date:  2012-03-30       Impact factor: 5.046

Review 2.  Sleep disturbance of adults with a brain tumor and their family caregivers: a systematic review.

Authors:  Megan Soohwa Jeon; Haryana M Dhillon; Meera R Agar
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

3.  Diagnostic Accuracy of Magnetic Resonance Spectroscopy in Predicting the Grade of Glioma Keeping Histopathology as the Gold Standard.

Authors:  Zunaira Rafique; Muhammad Wasim Awan; Shaghaf Iqbal; Naila Nasir Usmani; Mahjabeen Mahmood Kamal; Wajiha Arshad; Mashkoor Ahmad; Hassan Mumtaz; Shahzaib Ahmad; Mohammad Hasan
Journal:  Cureus       Date:  2022-02-09

Review 4.  Subtle neuropsychiatric symptoms of glioblastoma multiforme misdiagnosed as depression.

Authors:  Raphael Jerome Leo; Jill N Frodey; Matthew L Ruggieri
Journal:  BMJ Case Rep       Date:  2020-03-17

5.  Image and motor behavior for monitoring tumor growth in C6 glioma model.

Authors:  Taylla Klei Felix Souza; Mariana Penteado Nucci; Javier Bustamante Mamani; Helio Rodrigues da Silva; Daianne Maciely Carvalho Fantacini; Lucas Eduardo Botelho de Souza; Virginia Picanço-Castro; Dimas Tadeu Covas; Edson Luis Vidoto; Alberto Tannús; Lionel Fernel Gamarra
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.